Equities

Medinex Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Medinex Ltd

Actions
Health CareHealth Care Providers
  • Price (SGD)0.23
  • Today's Change0.00 / 0.00%
  • Shares traded41.60k
  • 1 Year change+6.98%
  • Beta0.1709
Data delayed at least 10 minutes, as of Feb 13 2026 08:50 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Financials data is unavailable for this security.

Inc stmt in SGDIncome statement in SGDView more

Year on year Medinex Ltd had relatively flat revenues (12.58m to 12.81m), though the company grew net income 174.35% from 1.03m to 2.83m. A reduction in the selling, general and administrative costs as a percentage of sales from 42.12% to 40.40% was a component in the net income growth despite flat revenues.
Gross margin77.93%
Net profit margin27.94%
Operating margin29.35%
Return on assets17.38%
Return on equity20.77%
Return on investment19.86%
More ▼

Cash flow in SGDView more

In 2025, Medinex Ltd increased its cash reserves by 7.47%, or 385.93k. The company earned 3.35m from its operations for a Cash Flow Margin of 26.14%. In addition the company generated 243.45k cash from investing, though they paid out 3.20m more in financing than they received.
Cash flow per share0.03
Price/Cash flow per share7.77
Book value per share0.1337
Tangible book value per share0.0691
More ▼

Balance sheet in SGDView more

Medinex Ltd has a Debt to Total Capital ratio of 6.41%, a lower figure than the previous year's 6.89%.
Current ratio2.89
Quick ratio2.75
Total debt/total equity0.0685
Total debt/total capital0.0641
More ▼

Growth rates in SGD

Year on year, growth in dividends per share remained flat while earnings per share excluding extraordinary items increased 169.01%.
Div yield(5 year avg)--
Div growth rate (5 year)--
Payout ratio (TTM)62.87%
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago
125.71
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.